Published in Ann Oncol on March 10, 2009
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol (2015) 1.67
Post-study therapy as a source of confounding in survival analysis of first-line studies in patients with advanced non-small-cell lung cancer. J Thorac Dis (2011) 0.92
The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of patients with advanced non-small cell lung cancer. Chin J Cancer (2013) 0.90
Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer. Curr Oncol (2014) 0.81
Comparison between cisplatin plus vinorelbine and cisplatin plus docetaxel in the treatment of advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials. Mol Clin Oncol (2013) 0.80
Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy. Medicine (Baltimore) (2016) 0.80
Non-small-cell lung cancer: should histology guide chemotherapy treatment? Ann Oncol (2009) 0.79
Does histology predict survival of advanced non-small cell lung cancer patients treated with platin-based chemotherapy? An analysis of the Eastern Cooperative Oncology Group Study E1594. Lung Cancer (2013) 0.78
Chemotherapy in Metastatic NSCLC - New Regimens (Pemetrexed, Nab-Paclitaxel). Front Oncol (2014) 0.77
Primary pulmonary adenocarcinoma in a 16-year-old boy - a five-year follow-up. Eur Clin Respir J (2016) 0.75
Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine - a Phase I trial. Onco Targets Ther (2017) 0.75
Docetaxel and Cisplatin regimen for non-small-cell lung cancer. Hosp Pharm (2013) 0.75
Docetaxel in the treatment of non-small cell lung carcinoma: an update and analysis. Lung Cancer (Auckl) (2010) 0.75
Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review. BMC Cancer (2016) 0.75
Efficacy of metronomic vinorelbine in elderly patients with advanced non-small-cell lung cancer and poor performance status. Curr Oncol (2017) 0.75
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. J Clin Oncol (2005) 5.82
BL-S640, a cephalosporin with a broad spectrum of antibacterial activity: bioavailability and therapeutic properties in rodents. Antimicrob Agents Chemother (1975) 4.31
Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL). Ann Oncol (2010) 3.40
Laboratory evaluation of BL-S786, a cephalosporin with broad-spectrum antibacterial activity. Antimicrob Agents Chemother (1976) 3.34
Microbiological evaluation of BB-K 8, a new semisynthetic aminoglycoside. J Antibiot (Tokyo) (1972) 3.09
Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics. Antimicrob Agents Chemother (1985) 2.87
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol (2000) 2.73
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. Ann Oncol (2002) 2.14
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer (1993) 2.08
Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest (1995) 2.06
BMY 28100, a new oral cephalosporin. Antimicrob Agents Chemother (1987) 2.03
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer. Ann Oncol (2011) 1.88
The cancer burden in Africa. S Afr Med J (2007) 1.79
Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial. Br J Cancer (2009) 1.54
Early corticosteroid use in acute exacerbations of chronic airflow obstruction. Am J Emerg Med (1996) 1.54
A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer. Breast (2010) 1.47
Czech Study on Lung Cancer Screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer (2000) 1.44
Spontaneous variability of cardiac output in ventilated critically ill patients. Crit Care Med (2000) 1.42
Irradiation of brain metastases from lung cancer: a retrospective study. Lung Cancer (1998) 1.40
[Recommendations on the therapy of bronchial carcinoma]. Pneumologie (2002) 1.39
Statement on withholding and withdrawing life-sustaining therapy. S Afr Med J (1994) 1.38
Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer. J Clin Oncol (2001) 1.32
Pulmonary actinomycosis appearing as a "ball-in-hole" on chest radiography and bronchoscopy. Thorax (1996) 1.24
Structure of general thoracic surgery in Europe. Eur J Cardiothorac Surg (2001) 1.24
In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm (2001) 1.19
T and B lymphocytes in pleural effusions. Chest (1978) 1.17
A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer. Ann Oncol (2011) 1.15
Corticosteroids in the treatment of tuberculous pleurisy. A double-blind, placebo-controlled, randomized study. Chest (1988) 1.14
Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer. Br J Cancer (2008) 1.14
Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma. Ann Oncol (2005) 1.14
A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer. Ann Oncol (2008) 1.13
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma. Blood (1997) 1.13
Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group. Ann Oncol (2002) 1.13
Gastric cancer in very young adults: apropos four patients and a review of the literature. J Cancer Res Clin Oncol (2000) 1.11
Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM). Ann Oncol (2007) 1.09
Acute disseminated intravascular coagulation syndrome in cancer patients. Oncology (1995) 1.07
Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. J Clin Oncol (2001) 1.04
Diagnostic value of total and differential leukocyte counts in pleural effusions. Acta Med Scand (1981) 1.04
Pneumocystis carinii pneumonia as a complication of bendamustine monotherapy in a patient with advanced progressive breast cancer. J Cancer Res Clin Oncol (2003) 1.04
Clinical efficacy of budesonide Turbuhaler compared with that of beclomethasone dipropionate pMDI with volumatic spacer. A 2-year randomized study in 102 asthma patients. Allergy (1994) 1.03
Regulation of in vitro mRNA transcription by a fraction of chromosomal proteins. J Biol Chem (1975) 1.02
Disseminated Nocardia asteroides infection in an immunocompetent woman following an arm injury. Infection (2003) 1.02
Pretreatment minimal staging and prognostic factors for non-small cell lung cancer. Lung Cancer (1997) 1.01
Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer. Ann Oncol (2002) 1.00
Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, pemetrexed disodium, ALIMTA) and cisplatin: a multicenter phase II trial. Ann Oncol (2000) 1.00
Time course of exhaled hydrogen peroxide and nitric oxide during chemotherapy. Eur Respir J (2006) 0.99
Dietary habits and lung cancer risk among non-smoking women. Eur J Cancer Prev (2004) 0.98
CT-guided percutaneous vertebroplasty: personal experience in the treatment of osteoporotic fractures and dorsolumbar metastases. Radiol Med (2008) 0.98
Local side-effects during 4-year treatment with inhaled corticosteroids--a comparison between pressurized metered-dose inhalers and Turbuhaler. Allergy (1994) 0.98
Dietary zinc supplementation inhibits NFkappaB activation and protects against chemically induced diabetes in CD1 mice. Exp Biol Med (Maywood) (2001) 0.97
Parasites of the German cockroach (Blattella germanica L.) in New York City. J Parasitol (1970) 0.96
Extracorporeal irradiation of thoracic duct lymph as immunosuppressive treatment in rheumatoid arthritis. Scand J Rheumatol (1976) 0.96
Type I and II collagen regulation of chondrogenic differentiation by mesenchymal progenitor cells. J Orthop Res (2005) 0.96
Lung cancer in situs inversus totalis (SIT)--literature review. Adv Med Sci (2013) 0.95
HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients. Br J Cancer (2005) 0.95
[Primary non-Hodgkin's lymphoma of the bone. Description of 2 cases]. Recenti Prog Med (1995) 0.94
Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients. J Clin Oncol (1998) 0.94
Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study. Ann Oncol (2006) 0.94
Acceptor proteins in rat androgenic tissue chromatin. Proc Natl Acad Sci U S A (1976) 0.94
Pneumococcal meningitis-therapeutic studies in mice. Chemotherapy (1975) 0.94
Antibacterial activity of phosphanilic acid, alone and in combination with trimethoprim. Antimicrob Agents Chemother (1985) 0.94
Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma. Chest (1988) 0.94
Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study. Br J Cancer (2007) 0.94
Prognostic factors in patients with advanced non-small cell lung cancer: data from the phase III FLEX study. Lung Cancer (2012) 0.93
Hypokalemic muscular paralysis causing acute respiratory failure due to rhabdomyolysis with renal tubular acidosis in a chronic glue sniffer. J Toxicol Clin Toxicol (2000) 0.93
Pulmonary mechanics in patients with prolonged mechanical ventilation requiring tracheostomy. Anaesth Intensive Care (1999) 0.91
Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG). Anticancer Res (2000) 0.91
Structure and activity of methylated horse liver alcohol dehydrogenase. Biochemistry (1974) 0.90
Treatment for collapsed lung in critically ill patients. Selective intrabronchial air insufflation using the fiberoptic bronchoscope. Chest (1990) 0.90
High pleural fluid hyaluronan concentrations in rheumatoid arthritis. Eur Respir J (1999) 0.90
Comparison of terbutaline and placebo from a pressurised metered dose inhaler and a dry powder inhaler in a subgroup of patients with asthma. Thorax (1994) 0.90
Pulmonary metastasizing hemangiopericytoma. Am J Clin Oncol (1988) 0.90
A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients. Ann Oncol (2001) 0.89
A case-control study of lifestyle and lung cancer associations by histological types. Neoplasma (2008) 0.89
Pneumonia preceding respiratory failure. A rare, easily misleading clinical manifestation in adult Arnold-Chiari malformation. Chest (1991) 0.89
Aspiration pneumonia following diesel oil siphonage--analysis of 12 cases. Changgeng Yi Xue Za Zhi (1988) 0.89
Association of tissue-specific histones with deoxyribonucleic acid. Thermal denaturation of native, partially dehistonized, and reconstituted chromatins. Biochemistry (1975) 0.89
Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients. Blood (1999) 0.89
Breast metastasis from gastric signet ring cell carcinoma, mimicking inflammatory carcinoma. A case report. Tumori (1993) 0.89
Severe non-haematological toxicity after treatment with gemcitabine. J Cancer Res Clin Oncol (1999) 0.88
Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone). Ann Oncol (1991) 0.88
Fever characteristics in tuberculosis--clinical observation in 597 cases. Changgeng Yi Xue Za Zhi (1989) 0.87
Resistance of macrophages to the suppressive effect of interleukin-10 following thermal injury. Am J Physiol Cell Physiol (2001) 0.87
Tissue-specific histones in the erythrocytes of chicken and turtle. Exp Cell Res (1975) 0.87
Serum and sputum levels of cefaclor. Postgrad Med J (1979) 0.87
Alveolar lavage fluid (ALF) of normal volunteer subjects: cytologic, immunocytochemical, and biochemical reference values. Respir Med (1995) 0.86
Cryptococcal meningitis and intracranial tuberculoma in a patient with Waldenstrom's macroglobulinemia treated with fludarabine. Leuk Lymphoma (1998) 0.86
Microflora and tetrodotoxin-producing bacteria in a gastropod, Niotha clathrata. Food Chem Toxicol (1995) 0.86
Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancer. Lung Cancer (2005) 0.86
High CXCR4 expression correlates with sunitinib poor response in metastatic renal cancer. Curr Cancer Drug Targets (2012) 0.86
Cellular response of antioxidant metalloproteins in Cu/Zn SOD transgenic mice exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol (2001) 0.86
The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancer. Lung Cancer (2000) 0.85
The preparation of norfloxacin-loaded liposomes and their in-vitro evaluation in pig's eye. J Pharm Pharmacol (1996) 0.85
Pleural fluid lysozyme in tuberculous and non-tuberculous pleurisy. Br Med J (1976) 0.85
Riu's stain in the diagnosis of pulmonary cryptococcosis. Introduction of a new diagnostic method. Chest (1988) 0.85
In vitro and in vivo antibacterial activities of BMY 40062, a new fluoronaphthyridone. Antimicrob Agents Chemother (1989) 0.85
Cations in component reactions of 'malic' enzyme catalysis. Biochem J (1971) 0.84